Rare versus common diseases: a false dichotomy in precision medicine

Abstract Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the extent to which these resources will be directed towards rare diseases (and cancers) versus comm...

Full description

Bibliographic Details
Main Authors: Brian Hon Yin Chung, Jeffrey Fong Ting Chau, Gane Ka-Shu Wong
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:npj Genomic Medicine
Online Access:https://doi.org/10.1038/s41525-021-00176-x

Similar Items